Literature DB >> 23356288

Atypical chemokine receptors: from silence to sound.

Cinzia Cancellieri1, Alessandro Vacchini, Massimo Locati, Raffaella Bonecchi, Elena M Borroni.   

Abstract

ACRs (atypical chemokine receptors) were initially referred to as 'silent' receptors on the basis of a lack of signalling and functional activities that are typically observed with conventional chemokine receptors. Although ACRs do not directly induce cell migration, they indirectly control leucocyte recruitment by shaping chemokine gradients in tissues through degradation, transcytosis or local concentration of their cognate ligands. Recent evidence also suggests that these biological activities are supported by G-protein-independent, β-arrestin-dependent signalling events. In the present article, we review current knowledge on structural and signalling properties of ACRs that are changing our view on this entire class of receptors from silent to endogenous β-arrestin-biased signalling receptors.

Mesh:

Substances:

Year:  2013        PMID: 23356288     DOI: 10.1042/BST20120246

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  16 in total

1.  The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Authors:  Lei-Ping Wang; Jun Cao; Jian Zhang; Bi-Yun Wang; Xi-Chun Hu; Zhi-Min Shao; Zhong-Hua Wang; Zhou-Luo Ou
Journal:  Med Oncol       Date:  2015-10-20       Impact factor: 3.064

2.  Regulation of motor function and behavior by atypical chemokine receptor 1.

Authors:  Erich H Schneider; Stephen C Fowler; Michail S Lionakis; Muthulekha Swamydas; Gibran Holmes; Vivian Diaz; Jeeva Munasinghe; Stephen C Peiper; Ji-Liang Gao; Philip M Murphy
Journal:  Behav Genet       Date:  2014-07-06       Impact factor: 2.805

3.  Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis.

Authors:  Juan Yang; Rong-Rong Miao; Ya-Nan Li; Ting Pan; Shu-Hua Wu; Xian-Jun Qu; Shu-Xiang Cui
Journal:  Acta Pharmacol Sin       Date:  2022-04-01       Impact factor: 6.150

4.  Molecular insights into mechanisms of GPCR hijacking by Staphylococcus aureus.

Authors:  Claire M Grison; Paul Lambey; Sylvain Jeannot; Elise Del Nero; Simon Fontanel; Fanny Peysson; Joyce Heuninck; Rémy Sounier; Thierry Durroux; Cédric Leyrat; Sébastien Granier; Cherine Bechara
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-19       Impact factor: 11.205

Review 5.  Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.

Authors:  K E Quinn; D I Mackie; K M Caron
Journal:  Cytokine       Date:  2018-09       Impact factor: 3.861

6.  High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma.

Authors:  Teng Hou; Dongxia Liang; Dong Yang; Jiehua He; Yongwen Huang; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 7.  Chemokines and chemokine receptors in multiple sclerosis.

Authors:  Wenjing Cheng; Guangjie Chen
Journal:  Mediators Inflamm       Date:  2014-01-02       Impact factor: 4.711

8.  Profiling of Cxcl12 receptors, Cxcr4 and Cxcr7 in murine testis development and a spermatogenic depletion model indicates a role for Cxcr7 in controlling Cxcl12 activity.

Authors:  Birgit Westernströer; Nicole Terwort; Jens Ehmcke; Joachim Wistuba; Stefan Schlatt; Nina Neuhaus
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

Review 9.  Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Authors:  Michael R Pranzatelli
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 10.  The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.

Authors:  Magdalena Groblewska; Ala Litman-Zawadzka; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.